The idea that intellectual property can serve as loan collateral is not new. Banks have accepted patent portfolios as security for decades in specialist transactions. What has changed is the scale of the opportunity. In an economy where intangible assets account for an estimated 60-70% of corporate value, the gap between where value resides and what lenders will accept as collateral represents a structural inefficiency that costs UK businesses billions in foregone capital each year.
This guide sets out the practical framework for using intellectual property as collateral in the UK: which IP categories are suitable, what the legal requirements are, how collateral suitability is assessed, and where the common pitfalls lie. It is intended for CFOs, founders, PE partners, and accountants who need to understand IP-secured lending — whether they are borrowers seeking capital-efficient financing or advisers structuring transactions.
60-70%
of corporate value is intangible
20-50%
typical LTV for IP collateral
£70B+
annual UK intangible investment
What Makes Intellectual Property Viable as Collateral
Not all intellectual property is suitable as loan collateral. Lenders assessing IP as security apply criteria that mirror the requirements for any asset class, adapted for the particular characteristics of intangible assets. Four factors determine whether a given piece of IP can realistically support a lending facility.
Separability. The IP must be capable of being separated from the business that created it. A patent can be transferred independently; tacit knowledge embedded in an engineering team cannot. Lenders need to know that if the borrower defaults, the collateral can be extracted and realised without requiring the original business to continue operating.
Transferability. Beyond separability, the IP must be legally and practically transferable. This means clear title, no encumbrances from prior licences that would impair value on transfer, and a plausible market of buyers or licensees. Registered IP — patents, trademarks, registered designs — scores highest on transferability because ownership is documented in public registries.
★ Key Takeaway
The four pillars of IP collateral viability are separability, transferability, legal enforceability, and measurable value. IP that fails on any one of these dimensions is unlikely to be accepted as security by a commercial lender.
Legal enforceability. The lender must be able to perfect a security interest in the IP and, if necessary, enforce that interest against third parties. In the UK, this requires registration at both the UK Intellectual Property Office (UK IPO) and Companies House. IP that exists outside a formal registration regime — trade secrets, for instance — presents enforcement challenges that most lenders are unwilling to accept as primary security.
Measurable value. The IP must be capable of reliable valuation using recognised methodologies. Lenders typically require an independent valuation conducted in accordance with the International Valuation Standards (IVS) or RICS Valuation Standards. The three standard approaches — income (including the relief-from-royalty method), market, and cost — must produce defensible figures that the lender's credit committee can underwrite.
The Five Categories of IP Collateral
Intellectual property is not a monolithic asset class. Each category has distinct characteristics that affect its suitability as collateral, the legal mechanism for taking security, and the loan-to-value ratio a lender is likely to offer.
Comparative Assessment of IP Categories as Collateral
| IP Category |
Typical LTV Range |
Legal Requirements for Security |
Strengths |
Limitations |
| Patents |
30-50% |
Register charge at UK IPO (Patents Act 1977, s.33) + Companies House (CA 2006, s.859A) |
Clear ownership via registration; defined term (20 years); licensable and transferable; established valuation methods |
Value declines as expiry approaches; narrow claims may limit utility; maintenance fees required; technology obsolescence risk |
| Trademarks |
25-45% |
Register charge at UK IPO (Trade Marks Act 1994, s.25) + Companies House |
Potentially indefinite life (renewable every 10 years); brand value can appreciate; broad consumer recognition |
Value tied to ongoing brand investment; dilution risk if improperly managed; class-specific protection only; geographic limitations |
| Copyrights |
20-40% |
No UK register for copyright; security by assignment or charge (CDPA 1988); register at Companies House |
Automatic protection (no registration cost); long duration (life of author + 70 years); covers software source code |
No public register makes title verification difficult; fair dealing exceptions; value often inseparable from creator; enforcement costs |
| Trade Secrets & Know-How |
10-25% |
Contractual security (debenture or assignment); no registration possible at IP registries; Companies House only |
Can be enormously valuable (e.g., manufacturing processes, algorithms); no expiry date |
No registration = no public record of ownership; value destroyed if disclosed; key-person dependency; difficult to value and enforce |
| Databases & Data Assets |
15-35% |
Database right under Copyright and Rights in Databases Regulations 1997; contractual security; Companies House |
Growing asset class; recurring data collection creates defensible moats; EU/UK sui generis database right |
Regulatory risk (GDPR/UK GDPR constraints on transfer); rapid depreciation if not maintained; valuation standards still maturing |
✔ Example
A UK-based pharmaceutical company with a portfolio of 12 granted patents protecting a novel drug delivery mechanism obtained a GBP 8 million facility from a specialist lender at 40% LTV against the patent portfolio's appraised value of GBP 20 million. The patents had 14 years remaining and were generating GBP 2.3 million per annum in licensing revenue — providing both collateral value and debt service coverage.
Patents
Patents are the most established form of intellectual property collateral. They benefit from clear registration at the UK IPO, defined terms, and well-understood valuation methodologies. The 20-year patent term (from filing date) creates a natural depreciation curve that lenders can model, and the existence of secondary markets for patent portfolios — particularly in technology and pharmaceuticals — provides a degree of liquidity that other IP categories lack.
The principal risk with patent collateral is technology obsolescence. A patent protecting a process that the market has moved beyond may have significant remaining term but negligible commercial value. Lenders typically require freedom-to-operate opinions and competitive landscape assessments alongside the valuation report.
Trademarks
Trademarks offer a distinctive advantage as collateral: unlike patents, they can appreciate in value over time and have no fixed expiry (provided renewal fees are paid every 10 years). A well-managed brand can generate increasing royalty streams as the business grows, making trademark portfolios attractive to lenders who take a longer-term view.
The limitation is that trademark value is inseparable from ongoing brand investment. A trademark that is not actively used and promoted will decline in value. Lenders taking security over trademarks typically include covenants requiring the borrower to maintain marketing expenditure and brand quality standards.
Copyrights
Copyright — which in the UK arises automatically without registration under the Copyright, Designs and Patents Act 1988 (CDPA) — covers a broad range of creative and functional works, including software source code, databases, literary works, and artistic content. The absence of a UK copyright register creates a significant challenge for lenders: there is no public record of ownership to verify, and perfection of a security interest cannot be achieved through registry filing.
ℹ Note
The UK has no copyright registration system. Lenders taking security over copyrights must rely on contractual assignments and debentures, with registration only at Companies House. This makes copyright collateral more complex to structure than registered IP rights such as patents or trademarks.
Lenders typically address this by requiring the borrower to provide chain-of-title documentation, employment agreements confirming IP assignment from creators, and escrow arrangements for source code.
Trade Secrets and Know-How
Trade secrets — encompassing proprietary processes, algorithms, formulae, customer lists, and undisclosed technical knowledge — can represent enormous economic value. The problem for lenders is that this value depends on secrecy. The moment a trade secret is disclosed (whether through a data breach, employee departure, or enforcement proceedings), its value may be destroyed entirely.
For this reason, trade secrets rarely serve as primary collateral. They may, however, form part of a broader IP portfolio that is pledged as security, with the lender accepting a blended LTV that reflects the mixed quality of the underlying assets.
Databases and Data Assets
Data assets are the newest category of intellectual property collateral and the one where valuation standards are least mature. The UK's sui generis database right (under the Copyright and Rights in Databases Regulations 1997) provides legal protection for databases that required substantial investment in their creation, but the transferability of data assets is constrained by data protection regulations — particularly the UK GDPR.
Lenders considering data assets as collateral must assess whether the data can be transferred to a third party on enforcement without breaching data protection obligations. Personal data is particularly problematic; anonymised or aggregated commercial data is more readily pledged.
The Legal Framework for IP Security Interests in the UK
The legal framework for taking security over intellectual property in the UK involves multiple statutory regimes that must be navigated concurrently. There is no single "IP security" statute; instead, the lender must comply with the requirements of the relevant IP legislation, company law, and (where applicable) property law.
Relevant Legislation
Intellectual Property Act 2014. This Act modernised the UK's IP framework and, among other reforms, introduced provisions for patent ownership disputes and streamlined the registration of transactions (including charges) at the UK IPO. It did not, however, create a unified register for IP security interests.
Companies Act 2006, Part 25 (ss.859A-859Q). Any charge created by a UK company over its assets — including intellectual property — must be registered at Companies House within 21 days of creation. Failure to register renders the charge void against a liquidator, administrator, or other creditors. This is a mandatory requirement regardless of whether the IP itself is registered at the UK IPO.
Law of Property Act 1925. For security by way of legal mortgage (as opposed to an equitable charge), the LPA 1925 provisions apply. In practice, most IP security is taken by way of equitable charge or assignment by way of security rather than legal mortgage, but the distinction matters for priority and enforcement.
Patents Act 1977, s.33. Transactions in patents — including the grant of security interests — must be registered at the UK IPO to be effective against third parties. An unregistered security interest in a patent may be defeated by a subsequent purchaser or chargee who registers first.
Trade Marks Act 1994, s.25. Security interests in registered trademarks must be registered at the UK IPO. The registrar maintains a record of charges and other transactions affecting registered marks.
The Moveable Transactions (Scotland) Act 2023
★ Key Takeaway
The Moveable Transactions (Scotland) Act 2023 introduces a Register of Assignations and a statutory pledge that, for the first time, allows Scottish businesses to grant non-possessory security over moveable assets — including intellectual property — without requiring incorporation. This creates a more borrower-friendly framework than currently exists under English law and may encourage lenders to offer IP-backed facilities to Scottish businesses.
This Act, which is expected to be fully commenced by 2025-2026, fundamentally reforms the law of security over moveable property in Scotland. It introduces a Register of Assignations (for assigning receivables) and a statutory pledge that can be used to create security over intellectual property and other moveable assets. For IP-backed lending, the significance is that Scottish businesses will have a clearer, more modern statutory framework for granting security over their IP than currently exists under English common law.
Perfecting a Security Interest in IP
The process of "perfecting" a security interest — making it enforceable against third parties and securing priority over subsequent creditors — requires multiple filings in the UK. The steps are sequential and time-sensitive.
Step 1: Due Diligence on Title
Verify ownership of all IP assets to be charged. For registered IP (patents, trademarks, designs), search the UK IPO register. For unregistered IP (copyright, trade secrets), review employment contracts, assignment agreements, and development records to confirm the chain of title.
Step 2: Draft the Security Agreement
The security instrument — typically a debenture incorporating a fixed charge over specific IP assets and a floating charge over future IP — must clearly identify each asset, describe the secured obligations, and include appropriate representations and warranties from the borrower regarding ownership and freedom from encumbrances.
Step 3: Register at the UK IPO
For patents, file Form 21 at the UK IPO. For trademarks, file Form TM16. Registration at the UK IPO gives notice to third parties and protects the lender's priority against subsequent dealings in the IP. There is no equivalent registration for copyrights or trade secrets.
Step 4: Register at Companies House
File the prescribed particulars of the charge at Companies House within 21 days of creation (Companies Act 2006, s.859A). This is mandatory for all charges created by UK companies, regardless of asset type. Late filing requires a court order.
Step 5: Ongoing Monitoring and Maintenance
After perfection, the lender must monitor the borrower's maintenance of the IP — including payment of renewal fees, prosecution of infringement claims, and compliance with any licensing obligations. Most security agreements include covenants requiring the borrower to notify the lender of material IP events.
Assessing Collateral Suitability
Not every piece of IP in a company's portfolio will be suitable as collateral. A structured scoring framework helps both borrowers and lenders identify which assets are worth pledging and which will not survive credit committee scrutiny.
Collateral Suitability Scoring Framework
The following five dimensions, each scored from 1 (weakest) to 5 (strongest), provide a standardised basis for evaluating IP collateral suitability:
| Dimension |
What It Measures |
Score 5 (Strongest) |
Score 1 (Weakest) |
| Legal Enforceability |
Can the lender enforce its security interest? |
Registered IP with clear title, no disputes, no prior charges |
Unregistered, contested ownership, multiple prior encumbrances |
| Revenue Attribution |
Does the IP generate identifiable revenue? |
Direct licensing revenue or royalty stream attributable to the IP |
No revenue directly attributable; value is purely defensive |
| Transferability |
Can the IP be sold or licensed independently? |
Active secondary market; multiple potential acquirers identified |
Fully embedded in the business; no independent market |
| Remaining Useful Life |
How long will the IP retain commercial value? |
10+ years of remaining legal protection and commercial relevance |
Less than 2 years; technology superseded or patent near expiry |
| Market Liquidity |
How quickly could the IP be realised? |
Comparable transactions available; specialist brokers active |
No comparable transactions; bespoke valuation required |
✔ Example
A software company's patent portfolio might score: Legal Enforceability 5 (registered, clear title), Revenue Attribution 4 (licensing programme generating GBP 1.2 million per annum), Transferability 3 (niche market but identifiable buyers), Remaining Useful Life 4 (12 years remaining), Market Liquidity 2 (limited comparable transactions). The aggregate score of 18/25 suggests strong collateral potential with appropriate structuring.
A composite score above 20 typically indicates IP that most specialist lenders would consider as primary security. Scores between 15 and 20 suggest the IP may serve as collateral within a broader portfolio. Below 15, the IP is unlikely to be accepted as standalone security.
The Role of Independent Valuation
Every IP-backed lending transaction requires an independent valuation. Lenders will not accept the borrower's internal assessment of IP value — nor should they. The valuation must be conducted by a qualified professional using IVS-compliant methodologies.
The three principal approaches are:
Income approach. The most commonly used method for IP with demonstrable revenue streams. The relief-from-royalty method estimates value by calculating the present value of hypothetical royalty payments that the owner avoids by owning the IP. The multi-period excess earnings method (MPEEM) isolates the earnings attributable to the IP after deducting returns on contributory assets.
Market approach. Estimates value by reference to comparable arm's-length transactions. Useful where licensing agreements or IP sales in the same sector are available, but data is often sparse — particularly for bespoke technology assets.
Cost approach. Estimates the cost to recreate or replace the IP. This approach typically produces the lowest values and is most appropriate for early-stage IP or defensive patents with no revenue attribution.
For lending purposes, the valuation report should include not only the current value but also a sensitivity analysis showing how value changes under adverse scenarios (revenue decline, competitive entry, shortened useful life). Lenders use these scenarios to stress-test the collateral gap and set appropriate LTV ratios.
Common Pitfalls in IP-Backed Lending
Several recurring issues undermine IP-backed lending transactions. Borrowers and their advisers should address these proactively.
Key-person dependency. IP whose value depends on the continued involvement of a specific individual — a named inventor, a lead scientist, a creative director — is inherently fragile as collateral. If that person leaves, the IP's commercial viability may collapse. Lenders typically require key-person insurance and non-compete agreements as conditions of the facility.
Technology obsolescence. The pace of technological change means that IP protecting current-generation technology may be worthless within 5 years. Patents in fast-moving sectors (software, semiconductor, consumer electronics) face particularly acute obsolescence risk. Lenders mitigate this by shortening loan terms, requiring periodic revaluation, and applying higher haircuts.
Narrow IP portfolios. A single patent or a small portfolio concentrated in one technology area presents concentration risk. If that patent is invalidated, designed around, or the market shifts, the lender's entire security position is compromised. Diversified IP portfolios — combining patents, trademarks, and copyright — provide more resilient collateral.
Licensing complications. Existing out-licences can impair collateral value if they grant broad rights that would survive the borrower's default. The lender must review all existing licence agreements to understand what rights a third-party acquirer would inherit — and whether those rights would undermine the value of the IP on enforcement.
Cross-border complexity. IP rights are territorial. A UK patent provides protection only in the UK. If the borrower's business operates across multiple jurisdictions, the lender may need to take security over parallel IP rights in each territory — each with its own registration and perfection requirements.
Pre-Transaction Checklist for Borrowers
Before approaching a lender about IP-backed financing, ensure you can demonstrate: (1) clear and unencumbered title to all IP to be pledged, (2) an independent IVS-compliant valuation dated within the past 12 months, (3) documented revenue streams attributable to the IP, (4) current maintenance status of all registered IP (fees paid, renewals up to date), and (5) a schedule of all existing licences, assignments, and charges affecting the IP.
How Opagio Supports IP Collateral Assessment
Assessing whether intellectual property is suitable as collateral has traditionally required manual review by specialist advisers — often taking weeks and costing tens of thousands of pounds. This creates a barrier for SMEs and mid-market businesses that may hold valuable IP but lack the resources to structure a lending proposal.
Opagio's growth platform automates the initial collateral suitability assessment across the full spectrum of intangible assets. The platform classifies assets using a comprehensive library of intangible asset types organised under The Opagio 12 value driver framework, scores each asset on the five collateral suitability dimensions outlined above, and identifies which assets in a portfolio are most likely to meet lender requirements.
This does not replace the independent valuation that a lender will require. It does, however, allow borrowers to identify their strongest IP assets, build a credible collateral schedule, and engage with lenders from a position of informed readiness rather than uncertainty.
For businesses looking to understand whether their IP portfolio could support a lending facility, the IP Lending Readiness Report provides a structured assessment covering legal enforceability, revenue attribution, transferability, remaining useful life, and market liquidity across your entire intangible asset portfolio. The IP Lending Eligibility Assessment offers a quick initial screening to determine whether your business meets the baseline criteria for IP-backed financing.
Looking Ahead: The Evolving UK IP Lending Market
The UK IP-backed lending market remains nascent compared with the United States, where firms such as Aon and specialist IP lenders have been active for over a decade. But several developments are creating momentum.
The British Business Bank's ongoing work to promote intangible asset lending, the maturation of valuation standards (with the IVSC increasingly addressing intangible-specific guidance), and legislative reforms such as the Moveable Transactions (Scotland) Act 2023 are all contributing to a more favourable environment. As lender confidence grows and valuation methodologies become more standardised, the collateral gap — the difference between a company's enterprise value and the assets lenders will accept as security — will narrow.
For businesses with strong IP portfolios, the opportunity is to prepare now: ensure ownership is clear, valuations are current, and revenue attribution is documented. The lenders are coming. The question is whether your IP portfolio will be ready.
Related reading:
Tony Hillier is Co-Founder of Opagio. His career spans senior executive roles at NM Rothschild & Sons, GEC Finance, and Financial Security Assurance (New York), where he specialised in structured finance, asset-backed securities, and cross-border transactions. He holds an MA from Balliol College, Oxford and an MBA with distinction. Meet the team.